Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids

Conditions

Pain

What is the purpose of this trial?

The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy.



Participation Guidelines

Age:
6 Years - 16 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Purdue Pharma LP
Dates:
November 2010
Last Updated:
May 27, 2014
Study HIC#:
1107008863

Clinicaltrials.gov ID: NCT01192295